Simplifying Global Compliance
Articles Tagged with ''Daily International Pharma Alert''
Sponsors wishing to test new high-risk drugs for the first time in human subjects are advised to conduct additional preliminary studies in some circumstances under a new draft guideline from the European Medicines Agency (EMEA). Read More
Taiwan's Development Center for Biotechnology has signed a nonexclusive research licensing deal with DSM Biologics, a unit of DSM Pharmaceutical Products, and Crucell, the companies announced. Read More
BioLineRx, an Israel-based drug-development company, announced it has signed license agreements to develop and commercialize two new therapeutic candidates. Read More
Canadian drugs sold to consumers in the U.S. via the internet last year were half what they were the year before, according to IMS Health researchers who blamed a variety of market factors for the dramatic plunge in sales volume. Read More
Germany and Italy have decided to recommend human papillomavirus (HPV) vaccination of girls and young women to prevent cervical cancer, Sanofi Pasteur MSD has announced. Read More
Serum Institute, India's largest vaccine manufacturer, has announced the launch of a locally developed haemophilus influenzae type b (HIB) vaccine. Read More
The World Health Organization (WHO) has added four tuberculosis (TB) drugs to its list of prequalified products. Read More
Last week's reversal of a district court ruling that blocked a challenge to a key Norvasc patent has triggered an early generic launch of the drug by Mylan Laboratories. Read More
Merck announced today that the European Commission has approved its once-a-day oral treatment for Type 2 diabetes, Januvia. Read More
MerLion Pharmaceuticals, a drug-discovery and development company based in Singapore, and Merck Banyu, a wholly owned Japanese subsidiary of Merck, have signed a two-year discovery and licensing agreement. Read More
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing